Neo Medical has announced the closure of a US$20.6M financing round, the proceeds of which will be used to support the accelerated commercial deployment, with a particular focus on the US market, of the company’s ADVISE augmented reality (AR) platform for spinal surgery. This latest round of funding featured Swisscom Ventures as lead investor.
Vincent Lefauconnier, Neo Medical CEO, said: “Over the past years, we have pushed our integrated physical platform for spinal surgery to levels never reached before, improving surgical outcomes, streamlining treatment cycles, and reducing environmental impacts, while lowering healthcare costs.
“Looking forward, we will focus on the commercial deployment of the digital component of our platform with ADVISE, which for the first time bring surgeons real-time AR visibility for patient-specific spinal treatment.”
Myoung-Ok Kwon, investment partner at Swisscom Ventures, added: “We have been deeply impressed with Neo Medical’s management team and their vision to digitalise the spinal surgery space. Swisscom Ventures is very excited to support the company with the roll-out of ADVISE and its expansion in the US market. The company is well positioned to scale up and reinforce its position as a global player.”
